In vitro activity of copper(II) complexes, loaded or unloaded into a nanostructured lipid system, against mycobacterium tuberculosis

International Journal of Molecular Sciences

Volumn 17, Issue 5, 2016, Pages

  da Silva, Patricia B ^a   de Souza, Paula C ^a   Calixto, Giovana Maria Fioramonti ^a   Lopes, Erica de O ^a   Frem, Regina C G ^a   Netto, Adelino V G ^a   Mauro, Antonio E ^a   Pavan, Fernando R ^a   Chorilli, Marlus ^a  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Artemia salina L; Copper(II) complexes; Cytotoxicity; Mycobacterium tuberculosis; Nanostructured lipid system; Tuberculosis

Indexed keywords

CHOLESTEROL; COPPER COMPLEX; ISONIAZID; NANOCOATING; OLEATE SODIUM; PHOSPHATIDYLCHOLINE; COORDINATION COMPOUND; COPPER; LIPID; NANOMATERIAL; TUBERCULOSTATIC AGENT;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CONTROLLED STUDY; FLOW KINETICS; HAPLORHINI; HUMAN; HUMAN CELL; IC50; IN VITRO STUDY; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; NORMAL HUMAN; PHYSICAL CHEMISTRY; PHYSICAL PARAMETERS; POLYDISPERSITY INDEX; SELECTIVITY INDEX; SHEAR STRESS; TUBERCULOSIS; ZETA POTENTIAL; ANIMAL; CELL LINE; CHEMISTRY; CHLOROCEBUS AETHIOPS; DRUG EFFECTS; MICROBIAL SENSITIVITY TEST; PARTICLE SIZE; PROCEDURES; VERO CELL LINE;

ANIMALS; ANTITUBERCULAR AGENTS; CELL LINE; CERCOPITHECUS AETHIOPS; COORDINATION COMPLEXES; COPPER; HUMANS; LIPIDS; MICE; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; NANOSTRUCTURES; PARTICLE SIZE; TUBERCULOSIS; VERO CELLS;

EID: 84968820446     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17050745     Document Type: Article

References (39)

1. World Health Organization. Global Tuberculosis Report 2014; World Health Organization Press: Geneva, Switzerland, 2014; p. 171.
2. World Health Organization. Global Tuberculosis Report 2015; World Health Organization Press: Geneva, Switzerland, 2015; p. 204.
3. Ronconi, L.; Sadler, P.J. Using coordination chemistry to design new medicines. Coord. Chem. Rev. 2007, 251, 1633-1648. [CrossRef]
4. Van Rijt, S.H.; Sadler, P.J. Current applications and future potential for bioinorganic chemistry in the development of anticancer drugs. Drug Discov. Today 2009, 14, 1089-1097. [CrossRef] [PubMed]
5. Sigel, H. Metal Ions in Biological Systems; Marcel Dekker: New York, NY, USA, 1974; Volume 3.
6. Sandbhor, U.; Padhye, S.; Billington, D.; Rathbone, D.; Franzblau, S.G.; Anson, C.E.; Powell, A.K. Metal complexes of carboxamidrazone analogs as antitubercular agents 1. Synthesis, X-ray crystal-structures, spectroscopic properties and antimycobacterial activity against Mycobacterium tuberculosis H37Rv. J. Inorg. Biochem. 2002, 90, 127-136. [CrossRef]
7. Kanwar, S.S.; Lumba, K.; Gupta, S.K.; Katoch, V.M.; Singh, P.; Mishra, A.K.; Kalia, S.B. Synthesis and mycobactericidal properties of metal complexes of isonicotinoyldithiocarbazic acid. Biotechnol. Lett. 2008, 30, 677-680. [CrossRef] [PubMed]
8. Maccari, R.; Ottana, R.; Bottari, B.; Rotondo, E.; Vigorita, M.G. In vitro advanced antimycobacterial screening of cobalt(II) and copper(II) complexes of fluorinated isonicotinoylhydrazones. Bioorg. Med. Chem. Lett. 2004, 14, 5731-5733. [CrossRef] [PubMed]
9. Bottari, B.; Maccari, R.; Monforte, F.; Ottanà, R.; Rotondo, E.; Vigorita, M.G. Isoniazid-related copper(II) and nickel(II) complexes with antimycobacterial in vitro activity. Part 9. Bioorg. Med. Chem. Lett. 2000, 10, 657-660. [CrossRef]
10. Mandewale, M.C.; Thorat, B.; Shelke, D.; Yamgar, R. Synthesis and biological evaluation of new hydrazone derivatives of quinoline and their Cu(II) and Zn(II) complexes against Mycobacterium tuberculosis. Bioinorg. Chem. Appl. 2015, 2015, 1-15. [CrossRef] [PubMed]
11. Joseph, J.; Nagashri, K.; Janaki, G.B. Novel metal based anti-tuberculosis agent: Synthesis, characterization, catalytic and pharmacological activities of copper complexes. Eur. J. Med. Chem. 2012, 49, 151-163. [CrossRef] [PubMed]
12. Silva, P.B.; Bonifacio, B.V.; Frem, R.C.G.; Godoy Netto, A.V.; Mauro, A.E.; Da Costa Ferreira, A.M.; Lopes, E.O.; Raddi, M.S.G.; Bauab, T.M.; Pavan, F.R.; et al. A nanostructured lipid system as a strategy to improve the in vitro antibacterial activity of copper(II) complexes. Molecules 2015, 20, 22534-22545. [CrossRef] [PubMed]
13. Silva, P.B.; Freitas, E.S.; Bernegossi, J.; Gonçalez, M.L.; Sato, M.R.; Leite, C.Q.F.; Pavan, F.R.; Chorilli, M. Nanotechnology-based drug delivery systems for treatment of tuberculosis—A review. J. Biomed. Nanotechnol. 2016, 12, 241-260. [CrossRef]
14. Freitas, E.S.; Silva, P.B.; Chorilli, M.; Batista, A.A.; Lopes, E.O.; Silva, M.M.; Leite, C.Q.F.; Pavan, F.R. Nanostructured lipid systems as a strategy to improve the in vitro cytotoxicity of ruthenium(II) compounds. Molecules 2014, 19, 5999-6008. [CrossRef] [PubMed]
15. Sato, M.R.; Silva, P.B.; Souza, R.A.; Santos, K.C.; Chorilli, M. Recent advances in nanoparticle carriers for coordination complexes. Curr. Top. Med. Chem. 2015, 15, 287-297. [CrossRef] [PubMed]
16. Santos, F.K.; Oyafuso, M.H.; Kiill, C.P.; Gremião, M.P.D.; Chorilli, M. Nanotechnology-based drug delivery systems for treatment of hyperproliferative skin dieases—A review. Curr. Nanosci. 2013, 9, 159-167.
17. Souza, A.L.R.; Kiill, C.P.; Santos, F.K.; Luz, G.M.; Chorilli, M.; Gremião, M.P.D. Nanotechnology-based drug delivery systems for dermatomycosis treatment. Curr. Nanosci. 2012, 8, 512-519. [CrossRef]
18. Alvarez, G.; Varela, J.; Marquez, P.; Gabay, M.; Rivas, C.A.; Cuchilla, K.; Echeverria, G.; Piro, O.; Chorilli, M.; Leal, S.; et al. Optimization of antitrypanosomatid agentes: Identification of nonmutagenic drug candidates with in vivo activity. J. Med. Chem. 2014, 57, 3894-3899. [CrossRef] [PubMed]
19. Cunha Junior, A.D.S.; Fialho, S.L.; Carneiro, L.B.; Oréfice, F. Microemulsions as drug delivery systems for topical ocular administration. Arq. Bras. Oftalmol. 2003, 63, 285-391.
20. Oliveira, M.B.; Calixto, G.; Graminha, M.; Cerecetto, H.; González, M.; Chorilli, M. Development, characterization, and in vitro biological performance of fluconazole-loaded microemulsions for the topical treatment of cutaneous leishmaniasis. BioMed Res. Int. 2015, 2015, 1-13.
21. Rigon, R.B.; Fachinetti, N.; Severino, P.; Santana, M.H.A.; Chorilli, M. Skin delivery and in vitro biological evaluation of trans-resveratrol-loaded solid lipid nanoparticles for skin disorder therapies. Molecules 2016, 21, 116-219. [CrossRef] [PubMed]
22. Mosca, M.; Ceglie, A.; Ambrosone, L. Effect of membrane composition on lipid oxidation in liposomes. Chem. Phys. Lipids 2011, 164, 158-165. [CrossRef] [PubMed]
23. Carvalho, F.C.; Calixto, G.M.F.; Hatakeyama, I.N.; Luz, G.M.; Gremião, M.P.; Chorilli, M. Rheological, mechanical, and bioadhesive behavior of hydrogels to optimize skin delivery systems. Drug Dev. Ind. Pharm. 2013, 39, 1750-1757. [CrossRef] [PubMed]
24. Calixto, G.M.F.; Yoshii, A.C.; Rocha e Silva, H.; Stringhetti Ferreira Cury, B.; Chorilli, M. Polyacrylic acid polymers hydrogels intended to topical drug delivery preparation and characterization. Pharm. Dev. Technol. 2015, 20, 490-496. [CrossRef] [PubMed]
25. Ceulemans, J.; Vinckier, I.; Ludwig, A. The use of xantan gum in an ophthalmic liquid dosage form: Rheological characterization of the interaction with mucin. J. Pharm. Sci. 2002, 91, 1117-1127. [CrossRef] [PubMed]
26. Palomino, J.C.; Martin, A.; Camacho, M.; Guerra, H.; Swings, J.; Portaels, F. Resazurin microtiter assay plate: Simple and inexpensive method for detection of drug resistance in Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 2002, 46, 2720-2722. [CrossRef] [PubMed]
27. Pavan, F.R.; Sato, D.N.; Leite, C.Q.F. An approach to the search for new drugs against tuberculosis. In Understanding Tuberculosis—New Approaches to Fighting Against Drug Resistance; Cardonar, P.J., Ed.; Intech: Rijeka, Croatia, 2012; pp. 147-156.
28. Gonçalez, M.L.; Marcussi, D.G.; Calixto, G.M.F.; Corrêa, M.A.; Chorilli, M. Structural characterization and in vitro antioxidant activity of kojic dipalmitate loaded w/o/w multiple emulsions intended for skin disorders. BioMed Res. Int. 2015, 2015, 1-8. [CrossRef] [PubMed]
29. Dos Santos Ramos, M.A.; Calixto, G.; de Toledo, L.G.; Bonifácio, B.V.; dos Santos, L.C.; de Almeida, M.T.; Chorilli, M.; Bauab, T.M. Liquid crystal precursor mucoadhesive system as a strategy to improve the prophylactic action of Syngonanthus. nitens (Bong.) Ruhland against infection by Candida krusei. Int. J. Nanomed. 2015, 10, 7455-7466. [CrossRef] [PubMed]
30. Cintra, G.A.D.S.; Pinto, L.A.; Calixto, G.M.F.; Soares, C.P.; Von Zuben, E.D.S.; Scarpa, M.V.; Chorilli, M. Bioadhesive surfactant systems for methotrexate skin delivery. Molecules 2016, 21, 231-239. [CrossRef] [PubMed]
31. Chuan, J.; Li, Y.; Yang, L.; Sun, X.; Zhang, Q.; Gong, T.; Zhang, Z. Enhanced rifampicin delivery to alveolar macrophages by solid lipid nanoparticles. J. Nanopart. Res. 2013, 15, 1634-1642. [CrossRef]
32. Orme, I. Search for new drugs for treatment of tuberculosis. Antimicrob. Agents Chemother. 2001, 45, 1943-1946. [PubMed]
33. Al-Adham, I.S.; Al-Hmoud, N.D.; Khalil, E.; Kierans, M.; Collier, P.J. Microemulsions are highly effective anti-biofilm agents. Lett. Appl. Microbiol. 2003, 36, 97-100. [CrossRef] [PubMed]
34. Parra, A.L.; Yhebra, R.S.; Sardiñas, I.G.; Buela, L.I. Comparative study of the assay of Artemia salina L. and the estimate of the medium lethal dose (LD50 value) in mice, to determine oral acute toxicity of plant extracts. Phytomedicine 2001, 8, 395-400.
35. Ferraz, K.O.; Wardell, S.M.; Wardell, J.L.; Louro, S.R.; Beraldo, H. Copper(II) complexes with 2-pyridineformamide-derived thiosemicarbazones: Spectral studies and toxicity against Artemia salina. Spectrochim. Acta A 2009, 73, 140-145. [CrossRef] [PubMed]
36. Formariz, T.P.; Chiavacci, L.A.; Scarpa, M.V.; Silva, A.A., Jr.; Egito, E.S.T.; Terrugi, C.H.B.; Franzini, C.M.; Sarmento, V.H.V.; Oliveira, A.G. Structure and viscoelastic behavior of pharmaceutical biocompatible anionic microemulsions containing the antitumoral drug compound doxorubicin. Colloids Surf. B 2010, 77, 47-53. [CrossRef] [PubMed]
37. Pavan, F.R.; Maia, P.I.; Leite, S.R.A.; Deflon, V.M.; Batista, A.A.; Sato, D.N.; Franzblau, S.G.; Leite, C.Q.F. Thiosemicarbazones, semicarbazones, dithiocarbazates and hydrazide/hydrazones: Anti-Mycobacterium tuberculosis activity and cytotoxicity. Eur. J. Med. Chem. 2010, 45, 1898-1905. [CrossRef] [PubMed]
38. Valdivieso-Garcia, A.; Clarke, R.C.; Rahn, K.; Durette, A.; MacLeod, D.L.; Gyles, C.L. Neutral red assay for measurement of quantitative Vero cell cytotoxicity. Appl. Environ. Microbiol. 1993, 59, 1981-1983. [PubMed]
39. Formariz, T.P.; Chiavacci, L.A.; Sarmento, V.H.V.; Franzini, C.M.; Silva, A.A., Jr.; Scarpa, M.V.; Santilli, C.V.; Egito, E.S.T.; Oliveira, A.G. Structural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin release. Colloids Surf. B 2008, 63, 287-295. [CrossRef] [PubMed]